Newer drugs for posthypoxic action myoclonus: observations from a well-studied case.
S
S
Fahn
D002998:Clonazepam / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005215:Fasting; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D000860:Hypoxia / Q000150:complications*; D008597:Menstrual Cycle; D008875:Middle Aged; D009207:Myoclonus / Q000188:drug therapy* / Q000209:etiology; D010389:Pemoline / Q000627:therapeutic use; D010889:Piracetam / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
D004966:Estrogens, Conjugated (USP); D006897:Hydroxyindoleacetic Acid; D002998:Clonazepam; D014635:Valproic Acid; D010389:Pemoline; D010889:Piracetam